ANTHEM-TIMI 32

ANTHEM-TIMI 32 assessed the efficacy and safety of anticoagulation with rNAPc2 in non-ST segment elevation acute coronary syndrome patients managed with an early invasive strategy.

DOWNLOAD SLIDE SET (PDF)

Key Study Publications

Giugliano, R. P., Wiviott, S. D., Stone, P. H., Simon, D. I., Schweiger, M. J., Bouchard, A., Leesar, M. A., Goulder, M. A., Deitcher, S. R., McCabe, C. H., Braunwald, E. Recombinant nematode anticoagulant protein c2 in patients with non-ST-segment elevation acute coronary syndrome: the ANTHEM-TIMI-32 trial J Am Coll Cardiol. 2007;49(25):2398-407. Abstract